Myriad Genetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.10.18	Myriad Signs Commercialization Plan With Pfizer - Quick Facts (RTTNews)
22.08.18	FDA Snubs Allergan, GNMX Gets Attention, Another Month, Another Suitor For CBPO (RTTNews)
21.08.18	Myriad Genetics Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
19.06.18	CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today (RTTNews)
18.06.18	Myriad: FDA To Review BRACAnalysis CDx Supplementary PMA - Quick Facts (RTTNews)
29.05.18	Myriad Genetics To Acquire Counsyl (RTTNews)
28.05.18	MYGN CASE NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN (PR Newswire)
19.05.18	MYGN ALERT: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action - MYGN (PR Newswire)
19.05.18	MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN (PR Newswire)
16.05.18	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN (PR Newswire)
08.05.18	Myriad Genetics Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
03.05.18	Investor Alert: Kaplan Fox Announces Investigation Of Myriad Genetics, Inc. (PR Newswire)
28.04.18	MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit... (PR Newswire)
28.04.18	RM LAW Announces Class Action Lawsuit Against Myriad Genetics, Inc. (PR Newswire)
25.04.18	Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against Myriad Genetics, Inc. (MYGN) (PR Newswire)
24.04.18	Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis... (PR Newswire)
23.04.18	Myriad Genetics Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. - MYGN (PR Newswire)
23.04.18	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline - June 19, 2018 (PR Newswire)
02.04.18	Myriad Reports Approval For BRACAnalysis Diagnostic System In Japan (RTTNews)
19.03.18	MYRIAD GENETICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Myriad Genetics, Inc. To Contact The Firm (PR Newswire)
15.03.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Myriad Genetics, Inc. (MYGN) (PR Newswire)
15.03.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myriad Genetics, Inc. - MYGN (PR Newswire)
15.03.18	Scott+Scott Attorneys at Law LLP Announces Investigation into Myriad Genetics, Inc. (MYGN) (PR Newswire)
07.02.18	GILD's Sales Wane, SGMO Safe With CHAMPIONS, All's Not Well With Veterinarians? (RTTNews)
06.02.18	Myriad Genetics Raises FY18 Financial Guidance - Quick Facts (RTTNews)
06.02.18	Myriad Genetics Inc. Q2 Income Advances (RTTNews)
03.01.18	Myriad, AstraZeneca Expand Collaboration To Include MyChoice HRD Plus Diagnostic (RTTNews)
12.12.17	Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib (RTTNews)
07.11.17	Myriad Genetics Inc. Q1 Income Climbs 14% (RTTNews)
03.11.17	DRNA Soars On NASH Deal, JUNO Transcends Expectations, FMI On Solid Footing (RTTNews)
19.10.17	Assurex: Study Shows GeneSight Statistically Improves Treatment Response In GAD (RTTNews)
02.10.17	Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month (PR Newswire)
07.09.17	Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month (PR Newswire)
08.08.17	Myriad Genetics Inc. Q4 Earnings Decline 21% (RTTNews)
04.05.17	Gainers & Losers Of May 3: PIRS, MYGN, XENT, RXDX, SPPI... (RTTNews)
03.05.17	Myriad Genetics Inc. Earnings Retreat 39% In Q3 (RTTNews)
02.05.17	Myriad Genetics Increases Annual Revenue Guidance, Narrows Adj. EPS Guidance (RTTNews)
27.04.17	Technical Roundup on Research Services Stocks -- Myriad Genetics, QIAGEN, INC Research, and Bioanalytical Systems (PR Newswire)
06.04.17	Myriad Genetics To Collaborate With BeiGene - Quick Facts (RTTNews)
21.03.17	Research Reports on Services Equities -- H&R Block, VCA Inc., Myriad, and QIAGEN (PR Newswire)
10.02.17	Myriad Genetics to Join S&P SmallCap 600 (PR Newswire)
07.02.17	Myriad Genetics Inc. Profit Drops 48% In Q2 (RTTNews)
13.01.17	How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta (PR Newswire)
09.12.16	Myriad: EndoPredict Test Outperforms In Predicting Breast Cancer Recurrence Risk (RTTNews)
02.12.16	Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta (PR Newswire)
01.11.16	Myriad Genetics Inc. Profit Retreats 46% In Q1 (RTTNews)
08.10.16	Myriad's myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib (GlobeNewswire)
09.08.16	Myriad Genetics Issues Q1, FY17 Guidance; Shares Plunge (RTTNews)
09.08.16	Myriad Genetics Inc. Q4 Profit Drops 10% (RTTNews)
11.07.16	Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

04.11.24		Börse New York in Rot: NASDAQ Composite gibt am Mittag nach
04.11.24		Verluste in New York: NASDAQ Composite beginnt Montagshandel mit Verlusten
01.11.24		Zuversicht in New York: Schlussendlich Gewinne im NASDAQ Composite
01.11.24		Freundlicher Handel: NASDAQ Composite zeigt sich am Freitagnachmittag fester
01.11.24		Pluszeichen in New York: NASDAQ Composite-Anleger greifen am Freitagmittag zu
01.11.24		NASDAQ Composite-Handel aktuell: Zum Start Gewinne im NASDAQ Composite
10.10.24		Minuszeichen in New York: NASDAQ Composite notiert zum Handelsende im Minus
09.10.24		NASDAQ-Handel: NASDAQ Composite schlussendlich mit positivem Vorzeichen

04.11.24

Börse New York in Rot: NASDAQ Composite gibt am Mittag nach

04.11.24

Verluste in New York: NASDAQ Composite beginnt Montagshandel mit Verlusten

01.11.24

Zuversicht in New York: Schlussendlich Gewinne im NASDAQ Composite

01.11.24

Freundlicher Handel: NASDAQ Composite zeigt sich am Freitagnachmittag fester

01.11.24

Pluszeichen in New York: NASDAQ Composite-Anleger greifen am Freitagmittag zu

01.11.24

NASDAQ Composite-Handel aktuell: Zum Start Gewinne im NASDAQ Composite